Fresh analysis indicates that people who stop using popular GLP-1 drugs like semaglutide or tirzepatide may regain lost weight at a significantly accelerated pace than those who end conventional diet and exercise programs.
Research printed in a major medical journal demonstrates that while obese individuals can lose substantial amounts of their body weight while on the medication, the mass returns at an estimated rate of 0.8 kg per month once they quit.
"Individuals buying these medications need to be cognizant of the potential of rapid rebound weight gain when the therapy ends," cautioned researcher Dr. Susan Jebb.
Such speed of recovery means a reversion to starting mass in about 18 months.
Weighing Treatments
The study, which examined 37 of studies involving thousands of patients, contrasted the outcomes of the injectable medications with older methods.
Researchers note that individuals who lose weight through lifestyle changes alone generally see a less rapid creep back—approximately 100 grams monthly—post-intervention.
The Reason for the Quick Rebound
Nutrition scientists propose the mode of action of the drugs accounts for the amplified weight return.
The injections mimic a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.
"Long-term administration of GLP-1 levels several times higher than normal might result in the system to produce less of its endogenous GLP-1, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a nutrition expert.
"Discontinuation of this medication leads to hunger is no longer kept in check, making excessive eating much more probable."
An Ongoing Disease?
The NHS suggest the injections for people with weight-linked health risks, accompanied by prescribed lifestyle changes.
A number of clinicians argue that, due to the significant potential of relapse, the therapy might need to be long-term.
This view is echoed by drug manufacturers, who state that the findings "underscore the persistent character of excess weight," akin to managing conditions like high blood pressure.
User Testimonies
People who have discontinued the jabs report a intense return of cravings.
"I experienced something activating and you're instantly starving," recalled an individual.
The struggle is exacerbated if users have not developed permanent lifestyle or habit modifications during therapy.
Significant Interest
Survey data suggest that millions of people in the UK have used these injections in the past year, with desire continuing to grow.
- Use is more common among women compared to males.
- The 40s and 50s age group shows the greatest usage rates.
- A large proportion obtain the drugs through private healthcare rather than the NHS.
In conclusion, experts emphasize that while these medications are effective agents for weight loss, they are not a magic fix and long-term success relies on combined lifestyle management.
